Sinjard-M 500 mg Tablet is a combination of Empagliflozin and Metformin Hydrochloride, used to manage Type 2 Diabetes Mellitus. Empagliflozin lowers blood glucose by increasing glucose excretion through urine, while Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity. This combination therapy is effective in improving glycemic control in adults with type 2 diabetes